Pharmafile Logo
Pharmafocus logo
Advanced Search

CBT

Showing 3 posts of 3 posts found.

national-cancer-institute-l8twzt4ccvq-unsplash_1

Swing Therapeutics receives FDA authorisation for digital therapeutic for fibromyalgia

May 22, 2023
Medical Communications CBT, Devices, FDA, Swing Therapeutics, fibromyalgia

Swing Therapeutics has announced that it has received De Novo marketing authorisation from the US Food and Drug Administration for …

News

“The future of pain care”: Virtual reality therapy proven to aid chronic pain

June 11, 2021
Medical Communications CBT, Virtual reality, chronic pain management, technology

A novel digital therapeutics software, DTxP, has shown statistically significant benefits for patients with chronic low back pain (CLBP) in …

News

NICE recommend digital CBT for young people with mild depression

January 23, 2019
Research and Development CBT, Digital CBT, NHS, psychology, psychotherapy

Britain’s cost effectiveness body NICE has recommended digital Cognitive Behavioural Therapy (CBT) for children with mild depression as a first …

News

Latest content

Prism BioLab and Ono Pharmaceutical enter joint research and licensing agreement

April 25, 2024

Ascendis Pharma’s Yorvipath approved by MHRA for hypoparathyroidism treatment

April 25, 2024

Eli Lilly acquires new manufacturing facility from Nexus Pharmaceuticals

April 24, 2024

GSK’s Jemperli accepted for FDA review for endometrial cancer treatment

April 24, 2024

Sanofi shares results for phase 3 LUNA 3 trial in immune thrombocytopenia

April 23, 2024